PET Clinics 2023 Vol-18 – N-3: Fibroblast Activation Protein Imaging

Preface: Fibroblast Activation Protein as a Diagnostic and Therapeutic Target: Where Do We Go from Here? xv
Rodney J. Hicks, Frederik L. Giesel, and Ken Herrmann

Advanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements
Stephen G. DiMagno and John W. Babich

Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer
Liang Zhao, Yizhen Pang, Long Sun, Qin Lin, Hua Wu, and Haojun Chen

The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma
Emil Novruzov, Yuriko Mori, and Fuad Novruzov

Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer
Manuel Röhrich

Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer
Esther Strating, Anne van de Loo, Sjoerd Elias, Marnix Lam, and Onno Kranenburg

Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer
Tadashi Watabe and Frederik L. Giesel

Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer
Katharina Dendl, Stefan A. Koerber, Tadashi Watabe, Uwe Haberkorn, and Frederik L. Giesel

Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma
Lukas Kessler

Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma
Rainer Hamacher, Helena Lanzafame, Ilektra A. Mavroeidi, Kim M. Pabst, Lukas Kessler,
Phyllis F. Cheung, Sebastian Bauer, Ken Herrmann, Hans-Ulrich Schildhaus, Jens T. Siveke,
and Wolfgang P. Fendler

Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor
Stefan A. Koerber

Imaging Fibrosis
Anna Sviridenko, Gianpaolo di Santo, and Irene Virgolini

Cardiac Applications of Fibroblast Activation Protein Imaging
Johanna Diekmann and Frank M. Bengel

Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations
Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, Yuichiro Kadonaga, and Tadashi Watabe

Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment
Katharina Lückerath, Marija Trajkovic-Arsic, and Christine E. Mona

Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation
Yuriko Mori, Clemens Kratochwil, Uwe Haberkorn, and Frederik L. Giesel

Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting Interventions
Sherly Mosessian, Jessica D. Jensen, and Aaron S. Enke